Work

Outcome of patients with recurrent/refractory osteosarcoma enrolled in three recent phase II trials: A report from the Children’s Oncology Group.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.11530

Authors: Seema Rao, Ruxu Han, Mark D. Krailo, Allen Buxton, Pooja Hingorani, Alexander J. Chou, Richard Greg Gorlick, Damon R. Reed, Katherine A. Janeway, Lisa M. Kopp, Brenda Weigel, Michael Isakoff

Institutions: Baylor College of Medicine, Children's Oncology Group, The University of Texas MD Anderson Cancer Center, Weill Cornell Medicine, Moffitt Cancer Center, Dana-Farber Cancer Institute, University of Arizona, University of Minnesota, Connecticut Children's Medical Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3166800336

Cites:

Cited by: 6

Related to: 10